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Abstract
Background: Detection of somatic mutations is one of the main goals of next generation DNA sequencing. A wide
range of experimental systems are available for the study of spontaneous or environmentally induced mutagenic
processes. However, most of the routinely used mutation calling algorithms are not optimised for the simultaneous
analysis of multiple samples, or for non-human experimental model systems with no reliable databases of common
genetic variations. Most standard tools either require numerous in-house post filtering steps with scarce documentation
or take an unpractically long time to run. To overcome these problems, we designed the streamlined IsoMut tool which
can be readily adapted to experimental scenarios where the goal is the identification of experimentally induced
mutations in multiple isogenic samples.
Methods: Using 30 isogenic samples, reliable cohorts of validated mutations were created for testing purposes. Optimal
values of the filtering parameters of IsoMut were determined in a thorough and strict optimization procedure based on
these test sets.
Results: We show that IsoMut, when tuned correctly, decreases the false positive rate compared to conventional
tools in a 30 sample experimental setup; and detects not only single nucleotide variations, but short insertions
and deletions as well. IsoMut can also be run more than a hundred times faster than the most precise state of art
tool, due its straightforward and easily understandable filtering algorithm.
Conclusions: IsoMut has already been successfully applied in multiple recent studies to find unique, treatment
induced mutations in sets of isogenic samples with very low false positive rates. These types of studies provide
an important contribution to determining the mutagenic effect of environmental agents or genetic defects, and
IsoMut turned out to be an invaluable tool in the analysis of such data.
Keywords: Next generation sequencing, Mutagenesis, Somatic mutation detection, Multiple isogenic samples,
Low false positive rate, Demonstrative algorithm
Background
Next generation sequencing offers a powerful tool to
investigate genetic aberrations in a comprehensive
manner on a wide scale, ranging from point mutations
[1] to large-scale genomic rearrangements [2]. How-
ever, low complexity genomic regions, artefacts pro-
duced by the NGS pipeline, and regions of homology
across diverse parts of the genome often make it diffi-
cult to produce a reliable call on a given somatic single
nucleotide variation (SNV) [3–6]. SNV identification is
further hampered when no information is available on
common variations among individuals (single nucleo-
tide polymorphisms – SNPs). A well-annotated refer-
ence genome, such as the human genome, and the use
of appropriate controls, such as sequencing of matching
germline DNA, can significantly reduce the effects of
these problems. However, in many experimental setups
such control reference genomes are not available. Also,
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even though NGS is a very effective way of genome
analysis, it generates sequencing errors that may be
falsely detected as mutations [7, 8].
While the human genome is relatively well-researched
and extensive effort was put into retrieving information
on variation among humans [9, 10] to reduce the detec-
tion of false positive mutations, the case of less com-
monly sequenced organisms and cell lines is different.
Also, the practice of repeat masking of the genome is
usually either unavailable or less reliable for non-human
organisms. As most publicly available mutation detec-
tion software tools are optimised for human genomes
and also for specific experimental scenarios such as can-
cer genome analysis, it may be expected that they do not
perform satisfactorily in many other experimental
designs.
One of the most common ways of overcoming these
difficulties and adjusting already existing software to the
special needs of a given experiment is running the tool
with default settings and applying in-house scripts with
little or no documentation to remove false positive calls.
These methods are rarely tested or optimised and do not
allow the straightforward reproduction of the results,
which presents a great disadvantage when one attempts
to compare scientific findings.
A specific, but relatively straightforward mutagenesis
experimental set-up involves a population of essen-
tially identical starting cells which over the course of
the experiment individual cells are expected to acquire
different treatment-induced sets of mutations. Such
experiments are routinely used to survey the muta-
genic effect of various drugs or environmental agents
[11, 12], to detect mutations that contribute to the
development of treatment resistance [13, 14], or to
identify mutagenic processes dependent on various
genetic backgrounds [15]. In the past, the read-out of
mutagenesis assays was commonly obtained from the
sequence of a single gene, but whole genome sequen-
cing can provide a broader, unbiased mutation dataset.
During our work on chicken DT40 cells, we found that
whole genome sequencing data from mutagenesis ex-
periments could not be processed with sufficient reli-
ability by routinely used mutation detection software,
such as VarScan 2 [16] or MuTect [17], even when
tuning the appropriate control parameters of the tools.
MuTect2, which was not yet available at the time of
this study, is a more sophisticated version of MuTect
and is able to detect indels (insertions and deletions)
besides SNVs, however it would have taken unfeasibly
long to run on our experimental data.
In this manuscript we describe a very fast method for
accurate somatic mutation calling that is adequate when
multiple, differently treated isogenic samples are investi-
gated, by using information from many available samples
to rule out false positives. Samples were derived from
single cell clones, and we made use of the assumption
that mutations are independent in each sample. There-
fore, our method identifies SNVs and short indels
present in a single sample only, filtering out SNPs, se-
quencing and alignment bias primarily on the basis that
the false positive calls tend to be present at the same
genomic location in multiple samples. This way, the
need for a well-annotated reference genome or pre-
existing databases of germline variants is eliminated.
IsoMut applies a very simple strategy for filtering by
using fixed thresholds for most of the filtering parame-
ters which are in clear connection with the actual se-
quencing data, allowing the user to easily interpret the
results without dwelling deep into statistical models. On
the other hand, IsoMut also provides an additional filter-
ing option which is based on the statistical Fisher’s exact
test and can be used to finely tune the results to remove
all false positive calls from control samples if such samples
are available. We successfully used IsoMut to measure the
mutagenic effect of common cancer chemotherapeutics
[18] and to determine the effect of DNA repair gene de-
fects on mutagenesis [19]. In this paper we present proof
for the accuracy of mutation detection using IsoMut.
Methods
Dataset
Our method was optimised using a dataset of whole
genome sequences, obtained from a panel of cell line
clones used for assessing the effect of various chemical
agents on mutagenesis. The DT40 chicken lymphoblas-
toma cell line [20] was used for the experiments; the
wild type and BRCA1-/- cell clones used in this work
were derived from a previous study [19]. Single cell
clones were isolated and expanded before sample prep-
aration. Instead of sequencing a mixture of genomes in a
population, this arrangement allowed us to derive the se-
quences of the individual cloned cells, as any mutation
arising during the clonal expansion would only be
present in a small proportion of the sequence reads and
thus filtered out during the analysis. The experimental
setup results in an expected number of 50–5000 muta-
tions in each sample, similar to or lower than the num-
ber of mutations found in cancer samples [21]. This
relatively low overall mutation rate made it crucial to
keep false positive mutations to an absolute minimum.
Altogether N = 30 samples were analysed, each of
them identified by a unique ID (see Additional file 1 for
detailed table). Samples differ from each other in both
their genotype (‘WT’ (wild type) or ‘Mutant1’) and their
treatment. Mutant1 samples carry a homozygous
BRCA1 mutation that deletes exons 6–8 of the gene
[19]. However, as the actual genotypes and treatments
are irrelevant to the purposes of this paper, only general
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names are used below. The genome sequences of sam-
ples with same genotype and treatment are not identi-
cal, as they arose from distinct cell clones. The only
identical samples in the dataset are two pairs (S12, S15
and S27, S30), which were acquired by sequencing the
same DNA preparation twice. The availability of repeat
samples allowed us to control for false positive muta-
tions occurring due to sequencing and alignment error.
Whole genome sequence data was obtained by Illumina
paired end sequencing with read sizes of 125 and 150
bases in two sequencing batches. The different read
lengths and variations in other sequencing parameters
among sample groups are not unusual in real studies and
present the substantial challenge of reliably comparing
genetic information that may have been influenced by
various kinds of instrumental and computational artefacts.
Sequencing data generated for this study have been
submitted to the European Nucleotide Archive (ENA;
http://www.ebi.ac.uk/ena/) under study accession num-
ber ERP014915.
Preparation of input files
As IsoMut uses BAM files as its input, and optimisation
steps described below were carried out on pileup files
generated from these, reads were first aligned to the
chicken (Gallus gallus) reference sequence Galgal4.73,
which was downloaded from Ensembl [22]. The align-
ment was made using the Burrows-Wheeler Alignment
Tool (BWA, version 0.7.5a-r405). The reference se-
quence was indexed with the BWT-SW algorithm [23],
which is recommended in the case of large genomes.
The alignments of paired-end reads were generated with
the bwa-mem algorithm [24]. Duplicated reads were re-
moved using the samblaster program [25]. Additionally
the aligned reads were realigned near indels by the
GATK IndelRealigner [26]. After the generation of BAM
files, a joint and filtered pileup file of all investigated
samples was created (using the samtools [27] mpileup
command with options ‘-B’ and ‘-Q 30’) for time man-
agement purposes, as we needed to have access to this
information repeatedly. Further details on the gener-
ation of pileup files can be found in Additional file 2
and Additional file 3.
Mutation detection method based on multi-sample
noise filtering
As the naïve approach of using commonly applied muta-
tion detection tools with the suggested default settings
failed to produce satisfactory results or could not detect
small indels (for details see the Discussion section), we
designed a filtering method that combines information
from all available samples and gives robust SNV and
indel calling with low false positive rate. A general over-
view of the method can be seen on Fig. 1. The method
looks for heterozygous mutations with respect to the ref-
erence genome, and filters out positions where other
samples also differ from the reference. This approach
ensures that ‘germline’ variations, present in multiple
samples, are not called as false ‘somatic’ mutations even
in the absence of an available SNP database. The other
common source of false positive mutation calls are align-
ment errors. Typically they occur at the same genome
positions in multiple samples, so with multi-sample fil-
tering they are easily eliminated.
Results were evaluated using a set of validated
genotype-specific SNVs (‘test sets’), the generation of
which is described below. The calculated true positive
and false positive rates (TPR/FPR) were used as indica-
tors of the goodness of the filtering and optimisation
was carried out based on these values.
Establishing SNV test sets
To measure false negatives and validate the SNV detection
results, we established two different high-confidence refer-
ence SNV sets from within our dataset. The test sets con-
sist altogether of around 4000 positions, which is a
sufficiently large number to calculate reliable estimates of
TPR and FPR values.
The cell clone whole genome sequence panel used
contains several isogenic samples of two different ge-
notypes (WT and Mutant 1) that underwent various
mutagenic treatments. Cell populations were grown
separately for some time, accumulating mutations, be-
fore the isolation of single clones for genome sequen-
cing. Therefore, we expected to find two types of SNVs
within our dataset. There should be treatment-induced,
primarily heterozygous SNVs present in individual
samples only. In addition, there would be SNVs arising
from the genetic differences of the starting WT and
Mutant 1 cell clones, which could be either heterozy-
gous or homozygous. Heterozygous SNVs of the latter
category were used as test set positions.
A plot of the mean reference nucleotide frequency
(rnf ) of all WT samples against the mean rnf of all Mu-
tant 1 samples readily identifies heterozygous SNVs
present in the Mutant 1 genotype at the [100, 50%] pos-
ition. Mutations present in the WT samples but not in
the Mutant 1 samples are clustered around [50, 100%]
(see Fig. 2a). Additional clusters around [100, 70] and
[70, 100%] are due to genomic regions with ploidy > 2 in
the experimental cell line. To verify this statement, we
replotted the previous figure using only disomic chro-
mosomes (Fig. 2b) and used the clusters on this latter
graph as test cohorts, as the resulting clusters have very
clear outlines and show no overlap with the rest of the
data. Thus all optimisation procedures were limited to
disomic chromosomes only, which proved to be suffi-
cient for the relatively stable DT40 genome [20]. In cases
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when ploidy varies greatly in the investigated genome, a
ploidy-specific optimisation should be carried out. Also,
it is impossible to separate loss of heterozygosity (LOH)
events from real germline mutations during test set gen-
eration. This is not a problem, as LOH regions can be
included in the reference sets for testing purposes, in-
creasing the number of positions which can be used for
statistical analysis.
The described method for generating test sets is ap-
plicable whenever two sample groups of related but
separate genetic origin are available. Details of the
very similar indel test set generation can be found in
Additional file 2. In-depth workflow of the test set
generation from pileup files for both SNVs and indels
is in Additional file 4.
Testing of different filtering methods
Regardless of the SNV detection method selected, the
above test sets can be used to determine their accuracy.
False positive rates (FPR) were calculated by running
IsoMut on all samples, and counting independent muta-
tions in pre-treatment starting cell clones and in the re-
peatedly sequenced identical control samples, in which
no independent mutations may be present. To obtain es-
timates for the true positive rate (TPR), we ran the algo-
rithm using the starting clone of one genotype and all
clones of the second genotype. This way, the genotype-
specific SNVs were detected as unique in the selected
starting clone, and the proportion of the respective
genotype-specific test set detected in this individual
sample was used as TPR. Further details can be found in
Additional file 2.
Defining filtering parameters to handle SNPs and
alignment noise
IsoMut detects somatic mutations by considering all input
samples and applying filtering criteria at each genomic
position. To effectively discard germline mutations and
Fig. 1 An overview of the testing and optimisation of the mutation detection method
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false positives arising from alignment noise, three basic fil-
tering parameters were introduced: a minimal threshold
for the ratio of the most common type of non-reference
reads in the investigated sample (sample_mut_freq_min),
a minimal threshold for the ratio of reference reads in the
noisiest non-selected (‘other’) sample (other_rnf_min) and
a coverage limit for the selected sample (sample_cov_min).
For detailed verification of using such filters, see
Additional file 5. These parameters were optimised
for the desired values of TPR and FPR using the
above described testing method.
This thorough optimisation procedure requires a very
specific experimental setup and is often not feasible with
the available set of sequencing data. Thus a more rapid
and convenient method is desired to adopt IsoMut to
specific needs. To provide a much simpler tuning
option, IsoMut calculates the S score value of each can-
didate mutation, which is inversely related to the prob-
ability of falsely categorising a position as a unique
mutation, thus high-confidence mutations have higher S
values than unlikely ones. More precisely, S is calculated
as the negative logarithm of the probability p, that given
the assumption that the distribution of bases in the two
noisiest samples (containing the most non-reference
reads) at the genomic position is the same, we would
observe the actual sequencing data. Thus a low p (high
S) value suggests that it is unlikely that the two investi-
gated samples have the same base-distribution, making
it likely that the noisiest sample indeed has a unique
mutation in the given position. The probability p is de-
termined by the Fisher’s exact statistical test. For more
details, see Additional file 2.
The availability of negative controls allows for a sim-
ple, yet effective tuning of IsoMut by setting an S score
threshold for more rapid results. In this case, a separate
optimisation can be carried out on SNVs, insertions and
deletions.
Post-processing
SNV and indel candidates were subjected to different
post-processing steps, the details of which can be found
in Additional file 2.
Results and discussion
Optimal threshold values
We tested IsoMut on whole genome sequences of
mutagen-treated cultured cells. In the tests described
below, worst case scenarios were considered. One test
for determining the FPR was the inclusion of only two
samples of a given genotype, which makes the testing
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procedure as strict as possible. (For more details, see
Additional file 2.) If samples are distributed more evenly
among genotypes, IsoMut can achieve even better re-
sults than the ones presented below, simply by adjusting
the S score parameter. (For an example, see Additional
file 6.) Filter threshold values were selected based on
TPR and FPR requirements. We tested the effect on
TPR and FPR of varying the sample_mut_freq_min filter
at different values of sample_cov_min coverage require-
ment and a fixed other_rnf_min = 0.93 (Fig. 3b). As the
depth of the sequencing data limits coverage thresholds,
we chose an intermediate, fixed sample_cov_min = 7
value for further optimising. At this value, we investi-
gated how varying sample_mut_freq_min at different
values of the other_rnf_min filtering parameter influ-
ences the relation of TPR and FPR (Fig. 3a). Depending
on the number of expected mutations in the investigated
samples, different FPR values can be tolerated. The inset
on Fig. 3a shows the corresponding maximal achievable
TPRs and optimal filtering parameters to arbitrarily
chosen FPR values. For the low FPR requirement of the
test sample set, a fixed parameter set of sample_mut_-
freq_min = 0.31, other_rnf_min = 0.93, sample_cov_min
= 7 provided the best TPR of 92%. Further parameter
settings with the respective TPR and FPR values can be
found in Additional file 7.
Effects of sample number and sequencing depth
To assess the effects of having smaller datasets with
fewer samples, different n sized subsets of the original
30 samples were investigated. Details on this technique
can be found in Additional file 2. When using fewer
samples, the outline of mutation clusters used for estab-
lishing a test set gets progressively more blurred (Fig. 2c),
but the number of lost and gained positions remains
relatively small (less than 6 and 4% of the original set,
respectively) even for only 10 samples. The dominant ef-
fect of reducing the number of available samples is an
increased FPR (Fig. 3d). For very strict parameter set-
tings the number of true positives also increases when
using smaller datasets. In case of the samples used for
demonstration here, to keep FPRs below 50 per genome
false positive rate (SNV/Gbp)
tr
ue
 p
os
iti
ve
 r
at
e 
(%
)
100
95
90
85
80
75
70
65
60
55
0.5
0.6
0.7
1.0ds
_f
ac
to
r
tr
ue
 p
os
iti
ve
 r
at
e 
(%
)
100
95
90
85
80
75
70
false positive rate (SNV/Gbp)
50 100 150 2000
8
10
12
14
18
24
30sa
m
pl
e 
nu
m
be
r
0.87
0.88
0.89
0.90
0.91
0.92
0.93
0.94
0.95
0.96
0.97
0.98
0.99
ot
he
r_
rn
f_
m
in
tr
ue
 p
os
iti
ve
 r
at
e 
(%
)
100
95
90
85
80
75
70
65
60
55
false positive rate (SNV/Gbp)
6
7
10
12
13
14
15sa
m
pl
e_
co
v_
m
in
tr
ue
 p
os
iti
ve
 r
at
e 
(%
)
100
95
90
85
80
75
70
65
60
55
false positive rate (SNV/Gbp)
5 10 15 20 25 30 35 40 45 50 5 10 15 20 25 30 35 40 45 50
5 10 15 20 25 30 35 40 45 50
0.90
0.92
0.93
0.94
0.95
0.96
0.97
0.98
0.99
FPR 
thresholds
(SNV/Gbp)
max. 
achievable 
TPR (%)
best 
sample_mut
_freq
best 
other_rnf
_min
< 7.5 52 0.5 0.93
0.96< 11.25 81 0.34
< 15.0 88 0.35 0.93
< 18.75 89 0.34 0.92
< 22.5 92 0.31 0.93
< 30.0 93 0.31 0.92
< 37.5 94 0.30 0.92
< 75.0 95 0.30 0.90
ot
he
r_
rn
f_
m
in
false positive rate (SNV/Gbp)
5 10 15 20 25 30 35 40 45 50
tr
ue
 p
os
iti
ve
 r
at
e 
(%
)
100
95
90
85
80
75
70
65
60
55
A B C
D E
fixed sample_cov_min
fixed other_rnf_min testing of S score 
effect of sample number effect of coverage
Fig. 3 Quality components resulting from different parameter settings and different datasets. a Effects of varying other_rnf_min (different curves)
and sample_mut_freq_min (along the curves) with constant sample_cov_min = 7. The inset contains maximal achievable TPRs for given FPR
thresholds with the optimal parameter settings. b Effects of changing sample_cov_min (different curves) and sample_mut_freq_min (along the
curves) with fixed other_rnf_min = 0.93. c Effects of varying other_rnf_min (different curves) and the S score parameter (along the curves) with
sample_cov_min = 5 and sample_mut_freq_min = 0.21. d Effects of varying the size of the dataset. Measurement points correspond to the
parameter settings of the inset of (a). Mean values and standard deviation of three randomly chosen datasets are shown (see Additional file 2).
e Effects of decreased sample coverage. Measurement points correspond to the parameter settings of the inset of (a). Mean values and standard
deviation of three randomly down-sampled measurements are shown (see Additional file 2)
Pipek et al. BMC Bioinformatics  (2017) 18:73 Page 6 of 11
(~1 GB) while maintaining a TPR of at least 85%, no
fewer than 14 samples are required for analysis.
To demonstrate how a decreased coverage in one of
the samples effects the results, we down-sampled the se-
quence read data of the Mutant 1 starting clone using
different down-sampling factors (ds_factors) of 0.7, 0.6
and 0.5 and recalculated TPRs and FPRs for the param-
eter settings shown in the inset of Fig. 3a. Further details
are included in Additional file 2. We found that having
70% of the original coverage had minimal impact on
mutation detection, but further decreasing the sequen-
cing depth produced lower TPR and higher FPR values.
As the Mutant 1 starting clone had a mean coverage of
21, we advise using samples with a mean coverage of at
least 15.
IsoMut software implementation – guidelines for different
experimental setups
We created an open-source C implementation of the
somatic mutation detection steps of the above algorithm
with a python wrapper for parallelisation (downloadable
from https://github.com/genomicshu/isomut). The tool
expects BAM files as its input and returns a list of de-
tected mutations (both SNVs and indels) by applying
predefined filtering parameters and a post-processing
step different for SNVs and indels (see Additional file 2)
in each genomic position. Thus an appropriate reference
genome is necessary for running IsoMut for alignment
purposes, but mutations are not detected based on dif-
ferences of the samples and the reference genome, but
on differences between investigated samples.
IsoMut can be applied whenever multiple isogenic
samples are available and unique mutations are sought.
Negative control samples should be used when possible.
These can be either pre-experiment starting clones or
DNA preparations sequenced multiple times, neither of
which should contain experiment-induced unique muta-
tions. With the availability of negative controls and a
positive control test mutation set, best results are
achieved by optimising the three IsoMut filtering param-
eters as demonstrated above.
However, the availability of negative controls also al-
lows for the tuning of the S score value for more rapid
results, skipping the generation of positive test sets.
An example run of the IsoMut tool is shown in
Additional file 6. In the following we present the
main steps of the analysis. The generation of BAM
alignment files is not included and should be carried
out separately, prior to running IsoMut.
1. Downloading and compiling IsoMut.
2. Modifying user-specific data in the example
script (file names, paths, filtering parameter values).
3. Running IsoMut.
4. Tuning of the S score threshold value to minimise
false positives in negative control samples.
The first three steps are necessary, the fourth one is
optional and requires the availability of negative control
sample(s). Whenever possible, this last fine-tuning step
is strongly encouraged and yields better results than
using the predefined filtering parameters only. For this
procedure we suggest choosing less strict values for the
sample_mut_freq_min and sample_cov_min filters, and
further filtering the results based on the S score (see
Additional file 6). The effects of tuning the S score value
and the other_rnf_min parameter with fixed sample_-
mut_freq_min = 0.21 and sample_cov_min = 5 is shown
in Fig. 3c. According to the figure, whenever a very low
(< 2 · 10−8) FPR is desired, we suggest choosing a strict
other_rnf_min value of 0.96 (or even larger for lower FPR).
When the FPR can exceed 30 per Gbp, less strict filtering
is advised, other_rnf_min can be decreased to around 0.9.
IsoMut default values are sample_mut_freq_min = 0.21,
sample_cov_min = 5 and other_rnf_min = 0.93.
In the absence of negative controls, step (4) should be
skipped and we advise using filtering values from the
inset of Fig. 3a fitting the desired FPR. In this case SNVs
and indels are detected with the same filtering thresh-
olds. More details on the performance of our method in
such cases can be found in Additional file 2. An example
run without using an S score threshold, with parameter
settings sample_mut_freq_min = 0.31, other_rnf_min =
0.93, sample_cov_min = 7 can be found on Fig. 4 for our
dataset. This resulted in an average of only 6 mutations
in starting clones or identical sample pairs (FPR ~ 6∙10−9),
even though the DT40 genome differs from the
chicken reference genome in 6.3 million SNPs [20].
On the other hand, differently treated samples have up
to 2790 mutations, proving that the lack of these in
untreated starting clones is not due to overly strict
filtering.
Advantages of a straightforward filtering algorithm
Although setting fixed thresholds for the above de-
scribed simple filtering parameters might appear un-
sophisticated, the approach has a general advantage over
complex statistical models besides being just as effective.
In spite of recent developments of bioinformatics soft-
ware and mutation calling algorithms, the unspoken
consensus remains that ambiguous mutation calls are
best verified by checking the raw sequencing data either
in a genome viewer (for example IGV [28]) or a pileup
file. The above filtering parameters are directly related
to the number of different bases detected at each gen-
omic position, making the evaluation of mutations very
straightforward, without the need for decoding the
meaning of different p-values.
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Performance comparison with standard tools
We developed IsoMut because we had found that stand-
ard tools could not detect both SNVs and indels in the
above described samples with the precision required for
biological interpretation without heavy additional in-house
filtering. Here we present a comparison with two very
popular software tools, VarScan 2 [16] and MuTect [17].
VarScan 2 was run in its tumor-normal comparison
mode for the two pairs of identical samples in our data-
set (see Additional file 8). (Twice for both pairs, switch-
ing the roles of ‘tumor’ and ‘normal’ samples each time.)
This way all mutations found by VarScan 2 are false pos-
itives. Filtering parameters and additional filtering steps
were applied according to the instructions provided in
[29]. The analysis resulted in 368, 410, 1264 and 922
mutations in samples S12, S15, S27 and S30 respectively.
On the other hand, the numbers of false positives using
IsoMut were 3, 1, 3 and 5 for the same samples. This
difference in performance is probably due to the fact
that VarScan 2 relies largely on filtering methods which
have proved to be successful in case of human genomes,
but are not available for our current dataset (dbSNP, re-
peat masking).
MuTect is not capable of detecting indels (however, its
recently released version, MuTect2 is, but was unavail-
able for download at the time of this study), but we
selected it for testing because besides normal-tumor
sample pairs, MuTect can also use a panel of normal
samples. With default settings, MuTect did not perform
efficiently for our dataset, but with our control samples
we were able to optimise MuTect’s LOD parameter
threshold (Additional file 9), and obtained good results.
Compared to MuTect IsoMut has similar characteris-
tics at very low false positive rates (0.7/Mbp mutations
detected at 0.5/Gbp FPR in our dataset), and it has
higher sensitivity when we allow for higher false posi-
tive rates (1/Mbp mutations detected by IsoMut and
0.75/Mbp mutations detected by MuTect at 1/Gbp
FPR, Additional file 10). Additionally we found that
IsoMut adapts significantly better to lower sample
numbers (Additional file 10).
To get an estimate of the runtimes of different soft-
ware, we ran IsoMut, MuTect, MuTect2 and VarScan 2
on the short chicken chromosome 28 (4.7 Mbp) using
the 30 samples described above. We used a modest com-
puter with a memory of 23 GB and 12 cores, with a per-
formance achievable in a high-end desktop computer.
VarScan 2 was run in somatic mode by comparing each
sample with its appropriate ‘normal’ pair, resulting in 30
comparisons. Both for MuTect and MuTect2, the gen-
eral guidelines provided online were followed. First a
unique panel of normal samples was created for each
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sample by combining the results of the artefact detection
runs of all other samples. After this preliminary step,
mutations were detected by comparing each sample with
its ‘normal’ pair using the previously generated panel of
normals. For further details on the used pipelines and
scripts see Additional file 11.
Using all resources of the above described computer,
IsoMut turned out to be around 170 times faster than
MuTect2, more than 40 times faster than MuTect and
more than 10 times faster than VarScan 2 (see Table 1).
Extrapolating to the whole chicken genome, mutation
analysis on the set of 30 samples using this 12-core com-
puter would take 5 h with IsoMut, but over 35 days with
Mutect2. The number of possible MuTect2, MuTect and
VarScan 2 processes that can be run in parallel is limited
by the finite memory of the computer, as all these soft-
ware use java tools which require several java virtual
machines when run in parallel. On the other hand, the
parallelisation of IsoMut is only limited by the number
cores on the computer and the runtime appears to be
mainly I/O bound. The performance of the three java
applications can be significantly improved by using a
high-performance computer with a memory of 100–
200 GB. However, high-end computer clusters have
limited availability, and IsoMut presents a great speed
advantage when using modest resources. Even though
it is not realistic to run any of the above tools on a sin-
gle core without parallelisation, for a more straightfor-
ward comparison the results of such a scenario are also
presented in Table 1, demonstrating similar perform-
ance advantages for IsoMut.
Conclusion
The described SNV identification method requires no
prior knowledge of genomic nucleotide polymorphisms
(SNPs). As these are expected to be present in all the
isogenic samples, they are filtered out based on their dif-
ference from the reference genome. The availability of a
non-mutated reference sample is also not necessary if
the mutated samples contain independently formed
mutations.
Using the experimental dataset to establish reference
test sets also presents a great advantage to currently
used alternative approaches, which usually use some in-
dependent procedure to validate a small number of
well-chosen SNVs [30, 31]. As this is usually done ex-
perimentally at a great cost of time and money, it is de-
sirable to generate test sets in a more efficient manner.
Using these test sets we demonstrated the optimisation of
filtering parameters for diploid chromosomes. This way
we were able to present filtering parameter settings suit-
able for different desired FPRs that can be used on data-
sets with no mutation-free control samples.
We designed IsoMut to be used in cases when mul-
tiple isogenic samples are available and unique muta-
tions are sought. It is easily adapted to cases when the
independence of mutations in certain sample subsets is
not guaranteed; in these cases all but one of these sam-
ple subsets should be excluded from the analysis, while
including several truly independent samples. Based on
down-sampling an experimental dataset, we can recom-
mend a minimum sample number of 14 and a minimum
short-read sequence coverage of 15.
We strongly recommend sequencing negative control
samples, and designed an adjustable approach that can
be conveniently and quickly optimised for any specific
dataset with such controls. This optimisation procedure
can also be applied to non-diploid regions, where each
level of ploidy should be treated separately.
Mutation analysis is widely used in the study of the
DNA damaging effect of environmental substances and
metabolism, DNA repair, cancer, and evolution. IsoMut
can aid these studies by providing a solution for the ac-
curate identification of SNVs and indels from pure iso-
genic samples such as cell clones or animal progeny
regardless of the species and the available data on gen-
omic polymorphisms.
Additional files
Additional file 1: Table of samples. List of samples used in the study.
Half the samples had wild type (‘WT’) and the other half’Mutant 1′
genotype. Samples underwent different types of mutagenic treatments,
which are also indicated in the table. (PDF 221 kb)
Additional file 2: Detailed methods. A detailed description of methods
for testing and mutation detection. (PDF 598 kb)
Table 1 Comparison of runtimes of different tools with all available resources
Tool 12 cores Single core
Number of parallel
processes
Runtime Equivalent runtime
on 1 Gb genome
Runtime relative
to IsoMut
Runtime Runtime relative
to IsoMut
IsoMut 12 1 min 24 s 4 h 56 min 1 7 min 1
VarScan 2 5–6 16 min 2 days 8 h 11 1 h 20 min 11
MuTect 6–7 1 h 7 min 9 days 20 h 48 4 h 55 min 42
MuTect2 4–5 4 h 35 days 5 h 171 21 h 6 min 178
Table of the runtime comparison of different mutation detection software using a computer with 23 GB memory and 12 cores or a single core only. The tools
were run on the 4.735 Mb chicken chromosome 28 using the 30-sample dataset used throughout this study
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Additional file 3: Generating pileup files. Scripts and pipeline for pileup
file generation. (HTML 223 kb)
Additional file 4: Generating SNV test sets. Workflow for the generation
of SNV test cohorts. (HTML 390 kb)
Additional file 5: Verification and description of filtering parameters. A
detailed verification of the chosen filtering parameters. (PDF 391 kb)
Additional file 6: Example run and tuning of IsoMut. An example run of
IsoMut on a reduced dataset for easy testing. (HTML 1353 kb)
Additional file 7: Table of tested parameter settings. List of tested
parameter settings with the resulting TPR and FPR values. (PDF 307 kb)
Additional file 8: Running VarScan 2 on our dataset. Computational details
and results of running VarScan 2 on the described dataset. (HTML 408 kb)
Additional file 9: Running MuTect on our dataset with default settings.
Computational details and results of running MuTect on the described
dataset without the tuning of the LOD parameter. (HTML 675 kb)
Additional file 10: Comparison of IsoMut and MuTect. Comparison of
false positives rates when running IsoMut versus running MuTect with a
finely tuned LOD parameter. (HTML 373 kb)
Additional file 11: Runtime comparison of standard tools and IsoMut. A
list of scripts and functions used to test the speed of standard mutation
detection tools and IsoMut, using all resources of the available computer
and using a single core only. (HTML 311 kb)
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